Dobson CM (2001) The structural basis of protein folding and its links with human disease. Philos Trans R Soc London Ser B Biol Sci 356:133–145
2. Dobson CM (2003) Protein folding and misfolding. Nature 426:884–890
3. Herczenik E, Gebbink MFBG (2008) Molecular and cellular aspects of protein misfolding and disease. FASEB J 22:2115–2133
4. Lambert MP, Barlow AK, Chromy BA, et al (1998) Diffusible, nonfibrillar ligands derived from Aβ1–42 are potent central nervous system neurotoxins. Proc Natl Acad Sci 95:6448–6453
5. Knowles TPJ, Waudby CA, Devlin GL, et al (2009) An analytical solution to the kinetics of breakable filament assembly. Science (80- ) 326:1533–1537
6. Galvin JE, Lee VM, Schmidt ML, et al (1999) Pathobiology of the Lewy body. Adv Neurol 80:313
7. Lotharius J, Brundin P (2002) Pathogenesis of Parkinson’s disease: dopamine, vesicles and α-synuclein. Nat Rev Neurosci 3:932–942
8. Hardy J, Cai H, Cookson MR, et al (2006) Genetics of Parkinson’s disease and parkinsonism. Ann Neurol 60:389–398
9. Giasson BI, Murray IVJ, Trojanowski JQ, Lee VM-Y (2001) A hydrophobic stretch of 12 amino acid residues in the middle of α-synuclein is essential for filament assembly. J Biol Chem 276:2380–2386
10. Dettmer U, Newman AJ, Soldner F, et al (2015) Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation. Nat Commun 6:1–16
11. Breydo L, Wu JW, Uversky VN (2012) α-Synuclein misfolding and Parkinson’s disease. Biochim Biophys Acta (BBA)-Molecular Basis Dis 1822:261–285
12. Dedmon MM, Christodoulou J, Wilson MR, Dobson CM (2005) Heat shock protein 70 inhibits α-synuclein fibril formation via preferential binding to prefibrillar species. J Biol Chem 280:14733–14740
13. Wilhelmus MMM, Boelens WC, Otte-Höller I, et al (2006) Small heat shock protein HspB8: its distribution in Alzheimer’s disease brains and its inhibition of amyloid-β protein aggregation and cerebrovascular amyloid-β toxicity. Acta Neuropathol 111:139–149
14. Willander H, Hermansson E, Johansson J, Presto J (2011) BRICHOS domain associated with lung fibrosis, dementia and cancer–a chaperone that prevents amyloid fibril formation? FEBS J 278:3893–3904
15. Hedlund J, Johansson J, Persson B (2009) BRICHOS-a superfamily of multidomain proteins with diverse functions. BMC Res Notes 2:180
16. Peng S, Fitzen M, Jörnvall H, Johansson J (2010) The extracellular domain of Bri2 (ITM2B) binds the ABri peptide (1–23) and amyloid β-peptide (Aβ1–40): Implications for Bri2 effects on processing of amyloid precursor protein and Aβ aggregation. Biochem Biophys Res Commun 393:356–361
17. Willander H, Presto J, Askarieh G, et al (2012) BRICHOS domains efficiently delay fibrillation of amyloid β-peptide. J Biol Chem 287:31608–31617
18. Sweeney P, Park H, Baumann M, et al (2017) Protein misfolding in neurodegenerative diseases: implications and strategies. Transl Neurodegener 6:6
19. Luheshi LM, Crowther DC, Dobson CM (2008) Protein misfolding and disease: from the test tube to the organism. Curr Opin Chem Biol 12:25–31
20. Baldwin AJ, Knowles TPJ, Tartaglia GG, et al (2011) Metastability of native proteins and the phenomenon of amyloid formation. J Am Chem Soc 133:14160–14163
21. Chiti F, Dobson CM (2006) Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75:333–366
22. Otzen DE (2013) Amyloid fibrils and prefibrillar aggregates: molecular and biological properties. John Wiley & Sons
23. Cheon M, Chang I, Mohanty S, et al (2007) Structural reorganisation and potential toxicity of oligomeric species formed during the assembly of amyloid fibrils. PLoS Comput Biol 3:
24. Wilson MR, Yerbury JJ, Poon S (2008) Potential roles of abundant extracellular chaperones in the control of amyloid formation and toxicity. Mol Biosyst 4:42–52
25. Broadley SA, Hartl FU (2009) The role of molecular chaperones in human misfolding diseases. FEBS Lett 583:2647–2653
26. Maiti P, Manna J, Veleri S, Frautschy S (2014) Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin. Biomed Res Int 2014:
27. Vashist S, Cushman M, Shorter J (2010) Applying Hsp104 to protein-misfolding disorders. Biochem Cell Biol 88:1–13
28. Zhang H, Xu L-Q, Perrett S (2011) Studying the effects of chaperones on amyloid fibril formation. Methods 53:285–294
29. Willander H, Askarieh G, Landreh M, et al (2012) High-resolution structure of a BRICHOS domain and its implications for anti-amyloid chaperone activity on lung surfactant protein C. Proc Natl Acad Sci 109:2325–2329
